(Sharecast News) - Whitbread: Barclays upgrades to overweight with a target price of 4,900p.
Tyman: Liberum reiterates buy with a target price of 300p.
Experian: Deutsche Bank upgrades to hold with a target price of 2,200p.
Burberry: Deutsche Bank reiterates hold with a target price of 2,010p.
AstraZeneca: Liberum Capital reiterates buy with a target price of 8,250p.
GlaxoSmithKline: Jefferies reiterates buy with a target price of 1,850p.
Workspace: Berenberg downgrades to sell with a target price of 950p.
Berkeley Group: Goldman Sachs downgrades to sell with a target price of 3,860p.
Burberry: Credit Suisse reiterates outperform with a target price of 2,700p.
Genus: Jefferies initiates hold with a target price of 3,272p.
Wetherspoon: Barclays reiterates overweight with a target price of 1,690p.
RHI Magnesita: Barclays reiterates overweight with a target price of 4,400p.
Ted Baker: RBC Capital Markets reiterates sector performer with a target price of 440p
Burberry (BRBY)
Wetherspoon (J.D) (JDW)
Astrazeneca (AZN)
Berkeley Group (BKG)
Tyman (TYMN)
Workspace (WKP)
Genus (GNS)
Experian (EXPN)
Glaxosmithkline (GSK)
Whitbread (WTB)
RHI Magnesita (RHIM)24 Apr 2024 17:06
CORRECT: No record close for FTSE 100; mixed trade in US
(Correcting day of the week in the opening sentence.)
